Paraneoplastic leukemoid reaction as a marker of tumor progression in non-small cell lung cancer

Cancer Treatment Communications

Volumn 4, Issue , 2015, Pages 15-18

  McCoach, Caroline E ^a   Rogers, Jessica G ^b   Dwyre, Denis M ^b   Jonas, Brian A ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

G CSF; Lung cancer; Paraneoplastic leukemoid reaction; RAS RAF MEK; Tumorigenesis

Indexed keywords

ALISERTIB; CARBOPLATIN; CISPLATIN; FLUORODEOXYGLUCOSE; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL; PEMETREXED;

ARTICLE; CASE REPORT; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED TOMOGRAPHY; COUGHING; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMAGE GUIDED BIOPSY; IMMUNOHISTOCHEMISTRY; INTENSITY MODULATED RADIATION THERAPY; LEUKEMOID REACTION; LEUKOCYTE COUNT; LEUKOCYTOSIS; LUNG ADENOCARCINOMA; LYMPHADENOPATHY; MALE; MIDDLE AGED; MITOSIS INHIBITION; NIGHT SWEAT; PNEUMONIA; POLYMERASE CHAIN REACTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT FEVER; TUMOR GROWTH; WEIGHT REDUCTION;

EID: 84947918818     PISSN: 22130896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctrc.2015.03.003     Document Type: Article

References (9)

1. Robinson W.A. Granulocytosis in neoplasia. Ann. N. Y. Acad. Sci. 1974, 230:212-218.
2. Asano S., Urabe A., Okabe T., Sato N., Kondo Y. Demonstration of granulopoietic factor(s) in the plasma of nude mice transplanted with a human lung cancer and in the tumor tissue. Blood 1977, 49(5):845-852.
3. Chakraborty S., Keenportz B., Woodward S., Anderson J., Colan D. Paraneoplastic leukemoid reaction in solid tumors. Am. J. Clin. Oncol. 2013, [Epub ahead of print] (PMID: 24145395).
4. Granger J.M., Kontoyiannis D.P. Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients: a retrospective, single-institution study. Cancer 2009, 115(17):3919-3923.
5. Kasuga I., Makino S., Kiyokawa H., Katoh H., Ebihara Y., Ohyashiki K. Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma. Cancer 2001, 92(9):2399-2405.
6. Phan V.T., Wu X., Cheng J.H., et al. Oncogenic RAS pathway activation promotes resistance to anti-VEGF therapy through G-CSF-induced neutrophil recruitment. Proc. Natl. Acad. Sci. USA 2013, 110(15):6079-6084.
7. Yang L., Huang J., Ren X., et al. Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 2008, 13(1):23-35.
8. Kowanetz M., Wu X., Lee J., et al. Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes. Proc. Natl. Acad. Sci. USA 2010, 107(50):21248-21255.
9. Zhong C., Qu X., Tan M., Meng Y.G., Ferrara N. Characterization and regulation of bv8 in human blood cells. Clin. Cancer Res. 2009, 15(8):2675-2684.